e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
What is new in interstitial lung diseases of known origin?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2020 - The respiratory microbiome and metabolome in chronic hypersensitivity pneumonitis
R. Invernizzi (London, United Kingdom)
Source:
Virtual Congress 2020 – What is new in interstitial lung diseases of known origin?
Session:
What is new in interstitial lung diseases of known origin?
Session type:
Oral Presentation
Number:
4573
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Invernizzi (London, United Kingdom). LSC - 2020 - The respiratory microbiome and metabolome in chronic hypersensitivity pneumonitis. 4573
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
The impact of anti-IgE treatment on the airway microbiome in asthma.
Does “UIPAF” really exist?
Related content which might interest you:
LSC - 2019 - The skin microbiome drives immune maturation and exacerbation of both skin and airway inflammation
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019
The microbiome in chronic respiratory diseases
Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice?
Year: 2017
Young Investigator session: Perinatal antibiotic treatment affects murine microbiota, immune responses, and pathology in models of allergic asthma and hypersensitivity pneumonitis
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
From culturomics to metagenomics: the mycobiome in chronic respiratory diseases
Source: Eur Respir Monogr 2019; 83: 88-118
Year: 2019
LSC - 2020 - Glutathione-S-transferase P promotes Interleukin-1ß-induced inflammation and metabolic reprogramming in mice with allergic airways disease
Source: Virtual Congress 2020 – New insights into asthma immunology: in mouse and men
Year: 2020
LSC - 2021 - The role of the systemic inflammation in bronchiectasis exacerbation frequency
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
The microbiome and childhood respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018
Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by electronic nose
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Hypersensitivity pneumonitis
Source: Respipedia Article
Year: 2018
It’s not just viruses - the airway microbiome, bacteria-virus interactions and childhood asthma
Source: International Congress 2018 – Infectious agents and childhood asthma
Year: 2018
The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 28 (152) 190045; 10.1183/16000617.0045-2019
Year: 2019
Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005
The development of the upper respiratory microbiome on infancy and the dysbiosis related with wheezing syndrome and health on children from the rural tropics of Ecuador
Source: Annual Congress 2013 –Viral infections
Year: 2013
LSC - 2020 - Impact on pulmonary, intestinal and metabolic compartments of chronic smoking exposure and unhealthy diet: a functional and multi-omic approach
Source: Virtual Congress 2020 – Effects of environmental exposures on lung pathology
Year: 2020
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Targeting the microbiome in respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018
Tracheobronchial collapses in acute asthmatic attack
Source: International Congress 2014 – Functional imaging
Year: 2014
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept